Spire Wealth Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$1.54K 2301
2025
Q4
$1.54K Hold
100
﹤0.01% 2141
2025
Q3
$993 Hold
100
﹤0.01% 2273
2025
Q2
$992 Hold
100
﹤0.01% 2282
2025
Q1
$1.3K Hold
100
﹤0.01% 2346
2024
Q4
$1.28K Hold
100
﹤0.01% 2327
2024
Q3
$1.11K Hold
100
﹤0.01% 2082
2024
Q2
$1.12K Hold
100
﹤0.01% 2105
2024
Q1
$1.24K Hold
100
﹤0.01% 2174
2023
Q4
$1.4K Hold
100
﹤0.01% 2214
2023
Q3
$1.48K Hold
100
﹤0.01% 2187
2023
Q2
$1.29K Hold
100
﹤0.01% 2266
2023
Q1
$981 Buy
+100
New +$1.07K ﹤0.01% 2393
2022
Q3
Sell
-400
Closed -$5K 2275
2022
Q2
$5K Hold
400
﹤0.01% 2119
2022
Q1
$4K Buy
400
+50
+14% +$607 ﹤0.01% 2274
2021
Q4
$5K Buy
350
+150
+75% +$2.47K ﹤0.01% 2551
2021
Q3
$4K Buy
+200
New +$2.66K ﹤0.01% 2331

Other funds holding DVAX

Spire Wealth Management's DVAX Position: Q1 2026 in Review

Spire Wealth Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 100 shares — an estimated $1.54K sold.

Spire Wealth Management first reported a position in DVAX in Q3 2021 and held it in 16 quarters. The position peaked at $5K in Q2 2022. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Spire Wealth Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Spire Wealth Management sold 100 Dynavax Technologies shares in Q1 2026, an estimated $1.54K.
  • Spire Wealth Management first reported a position in Dynavax Technologies in Q3 2021 and held it in 16 quarters.
  • Spire Wealth Management's Dynavax Technologies position peaked at $5K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Spire Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.